Japanese Trade Distributors Stock News

TSE:7203
TSE:7203Auto

Toyota Stock And Two Dividend Powerhouses With Hidden Income Drivers

With inflation, interest rate questions and uneven growth across regions, many investors are looking for steadier income from their portfolios. That is where Dividend Powerhouses with yields above 5% and a focus on well covered, growing and stable payouts can help anchor long term returns. While bond markets, central bank decisions and sector swings continue to move around, a short list of high yield dividend stocks that meet strict quality and sustainability tests can offer a clearer way to...
TSE:1944
TSE:1944Construction

Kinden (TSE:1944) Stock Could Be 17.7% Undervalued As It Studies A Stock Split

Kinden (TSE:1944) is drawing fresh attention after announcing it is studying ways to lower its investment unit size, including a potential stock split, in order to broaden access for investors and support market activity. See our latest analysis for Kinden. The latest study of a stock split comes after a strong run in Kinden’s shares, with a 1 month share price return of 11.87% and year to date share price return of 10.36%, while the 1 year total shareholder return of 95.95% and very large 5...
TSE:2502
TSE:2502Beverage

Asahi Group Holdings (TSE:2502) Stock Could Be 71% Below Fair Value After Guidance Cut

Asahi Group Holdings (TSE:2502) recently cut its 2025 earnings guidance after system failures linked to a cyberattack in Japan led to lower expected revenue, higher costs, and projected impairment and disruption related expenses. See our latest analysis for Asahi Group Holdings. Against this guidance cut, Asahi Group Holdings' recent share price performance has been weak, with a 30 day share price return of a 1.81% decline and a year to date share price return of an 8.95% decline, while the 1...
TSE:6966
TSE:6966Semiconductor

Mitsui High-tec (TSE:6966) Is Up 70.5% After Upgrading FY2027 Guidance Is The Bull Case Different?

Mitsui High-tec, Inc. recently raised its consolidated earnings guidance for the fiscal year ending January 31, 2027, now projecting net sales of ¥254,000 million, operating profit of ¥14,500 million, and profit attributable to owners of parent of ¥10,000 million, or ¥54.72 per basic share. The company attributed this upgrade to stronger-than-expected demand and favorable foreign exchange effects, which it expects will more than offset higher material costs linked to tensions in the Middle...
TSE:3086
TSE:3086Multiline Retail

Can J. Front Retailing’s Shift Beyond Department Stores Reframe Its Core Story (TSE:3086)?

In May 2026, J. Front Retailing Co., Ltd. reported a 12.1% year-over-year decline in consolidated sales, despite growth at some key urban Daimaru and Matsuzakaya stores and strong tenant demand at PARCO. The company is increasingly leaning on shopping center, payment and finance operations, as well as content-driven retail formats, to counter weaker department store and developer performance. We’ll now consider how the double-digit consolidated sales decline and renewed emphasis on...
TSE:6526
TSE:6526Semiconductor

3 Asian Stocks That May Be Undervalued In June 2026

As global markets navigate heightened inflation pressures and geopolitical tensions, Asia's stock markets present a mixed landscape with opportunities for discerning investors. Amid these conditions, identifying undervalued stocks requires a keen eye on companies with strong fundamentals and resilience to external economic shifts.
TSE:4507
TSE:4507Pharmaceuticals

The Bull Case For Shionogi (TSE:4507) Could Change Following Japan’s First Pediatric ADHD Digital Therapeutic Launch

Shionogi & Co., Ltd. has begun sales in Japan of EndeavorRide, the first approved digital therapeutic support app for pediatric ADHD, following favorable Phase 3 trial results in 164 patients aged 6–17. By introducing a regulated, app-based treatment that targets prefrontal cortex activity via Akili’s SSME (TM) technology, Shionogi is extending ADHD care beyond traditional psychosocial and drug therapies. We will now explore how the launch of this first-in-Japan pediatric ADHD digital...
TSE:285A
TSE:285ASemiconductor

Kioxia Stock And Two Healthy High Growth Stories To Watch

With inflation trends, energy prices and central bank decisions all pulling markets in different directions, many investors are looking for stocks where earnings are expected to grow and balance sheets still look reasonable. That is exactly what the Healthy high growth potential screener aims to capture, focusing on companies where analysts expect earnings growth over the next 3 years and that meet basic financial strength checks. In this article, you will see 3 of the stocks from this...
TSE:5801
TSE:5801Electrical

Furukawa Electric (TSE:5801) Stock Looks Fully Priced After New FY2027 Guidance

Furukawa Electric (TSE:5801) issued fresh consolidated guidance for the fiscal year ending March 31, 2027, outlining targets of ¥1,460,000 million in net sales, ¥95,000 million in operating profit, and ¥82,000 million in profit attributable to shareholders. See our latest analysis for Furukawa Electric. Furukawa Electric's latest guidance arrives after a sharp move in the share price, with a 1-day share price return of 2.84% and a 7-day share price return of 15.59%, offset by a 30-day share...
TSE:6594
TSE:6594Electrical

Is Nidec (TSE:6594) Trading Governance Continuity for Renewed Credibility Amid Accounting Probes?

Nidec Corporation has already held a Board meeting to propose amendments to its Articles of Incorporation and is set to shift key convening and chairing roles for shareholder and board meetings from the Founder and Executive Chairman to the board President, with the changes scheduled to take effect following the June 18, 2026 shareholder vote. Alongside this governance reshuffle, Nidec is also weighing a deadline extension for its latest Annual Securities Report as it investigates improper...
TSE:6226
TSE:6226Machinery

Asian Market Gems 3 Stocks Priced Below Estimated Value

Amidst a backdrop of geopolitical tensions and economic fluctuations, Asian markets have shown resilience with mixed performances across major indices. As investors navigate these complexities, identifying undervalued stocks becomes crucial as they may offer potential opportunities for growth in a volatile environment.
TSE:6323
TSE:6323Semiconductor

Founder Led Stocks One Recovery Play One Premium Bet One Rocket

With inflation, interest rates and energy prices all pulling markets in different directions, many investors are looking beyond short term headlines and focusing on who is actually running the companies they own. Founder led stocks bring leaders whose personal legacy is on the line, which can mean closer cost discipline, sharper capital allocation and clearer long term direction. This article looks at our Founder Led Companies screener and highlights three of the stocks identified by it,...
TSE:9468
TSE:9468Media

How Investors May Respond To Kadokawa (TSE:9468) Proxy Advisers Opposing CEO and Chair Reappointment

In June 2026, Oasis Management intensified its campaign against KADOKAWA CORPORATION’s leadership, urging shareholders to vote against CEO Takeshi Natsuno’s reappointment and supporting his dismissal amid governance, compliance, and performance concerns, while the Japan Fair Trade Commission reportedly prepared another recommendation related to freelance treatment. The effort gained momentum when both ISS and Glass Lewis, the leading proxy advisory firms, later advised investors to oppose...
TSE:8306
TSE:8306Banks

Mitsubishi UFJ Financial Group (TSE:8306) Stock Could Be 6.6% Overvalued After Stablecoin Push

Mitsubishi UFJ Financial Group (TSE:8306) is in focus after forming a joint council with Mizuho Bank and Sumitomo Mitsui Banking Corporation to develop a yen-backed stablecoin, targeting blockchain-based payments under Japan’s regulated stablecoin framework. See our latest analysis for Mitsubishi UFJ Financial Group. Alongside the stablecoin council and the decision to redeem its US$2.1b senior notes in 2026, Mitsubishi UFJ Financial Group shares have produced a 9.25% 1 month share price...
TSE:8050
TSE:8050Luxury

Seiko Group (TSE:8050) Stock Looks Stretched After Investment Unit Review

Event overview and why Seiko Group stock is in focus Seiko Group (TSE:8050) has drawn fresh attention after stating that it is considering a reduction in its investment unit. The company described this potential change as a way to broaden its investor base and improve share liquidity. See our latest analysis for Seiko Group. Investors appear to be responding to the potential investment unit reduction, with Seiko Group’s share price at ¥7,780 after a 7.31% 1 day share price return and a year...
TSE:9697
TSE:9697Entertainment

Capcom (TSE:9697) Stock Could Be 27.8% Undervalued After New Franchise Announcements

Capcom (TSE:9697) stock is back in focus after a cluster of product announcements, including new expansions for Dragon’s Dogma 2 and Monster Hunter Wilds, a Resident Evil remake and a revived Onimusha installment. See our latest analysis for Capcom. The recent suite of franchise updates appears to have caught investors’ attention, with a 1-day share price return of 4.82% and a 7-day share price return of 3.17%. The share price is still down over the year to date, however, and the 1-year total...
TSE:8253
TSE:8253Consumer Finance

Credit Saison (TSE:8253) Stock Could Be Cheap After New Guidance And Dividend Plan

Credit Saison (TSE:8253) has moved into focus after issuing fresh earnings guidance for the fiscal year ending March 2027 and outlining higher dividend plans, giving investors new data on expected cash flows and payouts. See our latest analysis for Credit Saison. The fresh earnings guidance and higher dividend plan appear to have fed into improving sentiment around Credit Saison, with a 1-day share price return of 3.34% and year to date share price return of 5.35%. At the same time, longer...
TSE:4151
TSE:4151Pharmaceuticals

Is Strong MRD Clearance With Ziftomenib Reshaping The Investment Case For Kyowa Kirin (TSE:4151)?

Kura Oncology and Kyowa Kirin recently reported encouraging long-term Phase 1/2 KOMET-007 results showing that investigational ziftomenib plus 7+3 chemotherapy produced high remission rates, deep molecular responses and a manageable safety profile in newly diagnosed NPM1-m or KMT2A-r acute myeloid leukemia. A distinctive feature of the data is the high rate of early, deep minimal residual disease negativity alongside low treatment-related mortality, highlighting the regimen’s potential to...